中文 | English
Return
Total: 701 , 1/71
Show Home Prev Next End page: GO
Author:(Yu-Ling ZHOU)

1.Syndrome Element Distribution and Complication Risks in Type 2 Diabetic Patients:A Retrospective Cross-Sectional Study

Yu WEI ; Lili ZHANG ; Ling ZHOU ; Linhua ZHAO ; Qing NI ; Xiaolin TONG

Journal of Traditional Chinese Medicine 2025;66(13):1363-1368

2.Antibody threshold and demographic characteristics of low-titer group O whole blood donors in Jiangsu

Tao FENG ; Rui ZHU ; Wenjia HU ; Ling MA ; Hong LIN ; Xi YU ; Chun ZHOU ; Nizhen JIANG

Chinese Journal of Blood Transfusion 2025;38(9):1225-1229

3. The neuroprotective effects of Herba siegesbeckiae extract on cerebral ischemia/reperfusion in rats

Hui-Ling WU ; Qing-Qing WU ; Jing-Quan CHEN ; Bin-Bin ZHOU ; Zheng-Shuang YU ; Ze-Lin YANG ; Wen-Fang LAI ; Gui-Zhu HONG

Chinese Pharmacological Bulletin 2024;40(1):70-75

4.Efficacy of Fuzheng Hejie Prescription in the Treatment of Respiratory Viral Infection in Children and Its Effect on Immune Function

Xin-Yi LI ; Zong-Kan HU ; Yu XIE ; Wen-Ting MA ; Rong-Fang ZHOU ; Qi LYU ; Jie-Yu ZAN ; Ling-Fang ZHOU ; Ze-Ting YUAN

Journal of Guangzhou University of Traditional Chinese Medicine 2024;41(3):631-637

5.Risk factors for healthcare-associated bloodstream infection of carbape-nem-resistant Enterobacterales

Ling-Li YU ; Ying-Li ZHOU ; Meng-Meng DUAN ; Yu-Xia BAI ; Wen-Bin ZHANG

Chinese Journal of Infection Control 2024;23(1):100-103

6.Exploration on Medication Law of TCM Treatment for Chronic Bronchitis Based on Real World Data

Mengmeng QU ; Ning XU ; Ling ZHOU ; Yunyan QU ; Wei WANG ; Tingting ZHANG ; Mei GAO ; Junzhu JI ; Jiawen YAN ; Haibin YU

Chinese Journal of Information on Traditional Chinese Medicine 2024;31(2):50-58

7.Discussion of the methodology and implementation steps for assessing the causality of adverse event

Hong FANG ; Shuo-Peng JIA ; Hai-Xue WANG ; Xiao-Jing PEI ; Min LIU ; An-Qi YU ; Ling-Yun ZHOU ; Fang-Fang SHI ; Shu-Jie LU ; Shu-Hang WANG ; Yue YU ; Dan-Dan CUI ; Yu TANG ; Ning LI ; Ze-Huai WEN

The Chinese Journal of Clinical Pharmacology 2024;40(2):299-304

8.Clinical trial of Morinda officinalis oligosaccharides in the continuation treatment of adults with mild and moderate depression

Shu-Zhe ZHOU ; Zu-Cheng HAN ; Xiu-Zhen WANG ; Yan-Qing CHEN ; Ya-Ling HU ; Xue-Qin YU ; Bin-Hong WANG ; Guo-Zhen FAN ; Hong SANG ; Ying HAI ; Zhi-Jie JIA ; Zhan-Min WANG ; Yan WEI ; Jian-Guo ZHU ; Xue-Qin SONG ; Zhi-Dong LIU ; Li KUANG ; Hong-Ming WANG ; Feng TIAN ; Yu-Xin LI ; Ling ZHANG ; Hai LIN ; Bin WU ; Chao-Ying WANG ; Chang LIU ; Jia-Fan SUN ; Shao-Xiao YAN ; Jun LIU ; Shou-Fu XIE ; Mao-Sheng FANG ; Wei-Feng MI ; Hong-Yan ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(6):815-819

9.Study on the anti-inflammatory mechanism of active ingredients of Gubi Formula in the treatment of osteoarthritis

Peng DING ; Feng-Xiang TIAN ; Li XU ; Yu GE ; Fu-Rong WANG ; Yu-Jie BAO ; Ling-Ling ZHOU

The Chinese Journal of Clinical Pharmacology 2024;40(14):2053-2057

10.HNRNPA1 gene is highly expressed in colorectal cancer:its prognostic implications and potential as a therapeutic target

Kai JI ; Guanyu YU ; Leqi ZHOU ; Tianshuai ZHANG ; Qianlong LING ; Wenjiang MAN ; Bing ZHU ; Wei ZHANG

Journal of Southern Medical University 2024;44(9):1685-1695

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 701 , 1/71 Show Home Prev Next End page: GO